Table 4.
Survivor | Nonsurvivor | Crude OR (95% CI, p) | Adjusted OR (95% CI, p) | ||
---|---|---|---|---|---|
Age | Mean (SD) | 48.9 (15.4) | 63.5 (14.8) | 1.06 (1.05–1.08, p < 0.001) | 1.05 (1.03–1.08, p < 0.001) |
Hypertension | Yes | 263 (81.2) | 61 (18.8) | 5.46 (3.41–8.97, p < 0.001) | 2.25 (1.10–4.67, p = 0.028) |
DM | Yes | 288 (86.0) | 47 (14.0) | 2.39 (1.54–3.75, p < 0.001) | 1.14 (0.59–2.23, p = 0.697) |
CVD | Yes | 60 (75.9) | 19 (24.1) | 3.80 (2.10–6.63, p < 0.001) | 2.45 (1.10–5.43, p = 0.027) |
SOB | Yes | 250 (80.9) | 59 (19.1) | 5.27 (3.31–8.56, p < 0.001) | 4.07 (2.27–7.52, p < 0.001) |
ACE inhibitors | Yes | 71 (81.6) | 16 (18.4) | 3.32 (1.74–6.05, p < 0.001) | 1.84 (0.84–3.93, p = 0.121) |
Statin | Yes | 182 (83.1) | 37 (16.9) | 3.60 (2.20–5.92, p < 0.001) | 0.56 (0.25–1.20, p = 0.142) |
The values are N (%) unless specified otherwise. ACE, angiotensin-converting enzyme; CI, confidence interval; COVID-19, coronavirus disease; CVD, cardiovascular disease; DM, diabetes mellitus; OR, odds ratio; SD, standard deviation; SOB, shortness of breath.